Tecan

Mannedorf, Switzerland Founded: 1980 • Age: 46 yrs Listed
Automated laboratory instruments, robotics, and diagnostic solutions are provided.

About Tecan

Tecan is a company based in Mannedorf (Switzerland) founded in 1980. The company has 3,590 employees. Tecan has completed 7 acquisitions, including IBL International, NuGEN and Paramit. Tecan operates in a competitive market with competitors including Opentrons, Waters Corporation, Emerald Therapeutics, Andrew Alliance and Quartzy, among others.

  • Headquarter Mannedorf, Switzerland
  • Employees 3,590
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website tecan.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Tecan Group Ag
Key Metrics
  • Annual Revenue
    $1.11 B (USD)
    -5.54
    as on Dec 31, 2025
  • Net Profit
    -$139.59 M (USD)
    -263.53
    as on Dec 31, 2025
  • EBITDA
    $108.78 M (USD)
    -39.05
    as on Dec 31, 2025
  • Latest Funding Round
    $32.9M (USD), Grant

    Oct 2020

  • Investors
    HHS

    & 2 more

  • Employee Count
    3,590
  • Investments & Acquisitions

Apps and channels of Tecan

its YouTube channel Tecan has 1.67K subscribers and 30 videos.

Tecan
YouTube 1.67K subscribers 30 videos Science & Technology
Open channel

Videos from Tecan

The most watched videos on Tecan's YouTube channel, Tecan (1.67K subscribers). Click a video to play it here.

How to install your new Infinite® 200 PRO microplate reader and i-control™ software
5.7K views
How to install your new Sunrise™ microplate reader and Magellan™ software
3.2K views
How to install your new Infinite® F50 microplate reader and Magellan™ software
3K views
How to work with the injector module for the Spark® multimode reader
3K views

More on Tecan.

Funding Insights of Tecan

  • Total Rounds 5
  • Last Round Grant — $32.9M
  • Investors Count 3

All 5 funding rounds of Tecan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2020$32.9MGrant––
Sep 2016$414,466Grant––
May 2016$40,905Grant––
Jan 2016$401,204Grant––
Jun 2015–Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Tecan

Tecan has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and U.S. Department of Defense.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Military forces are provided by the U.S. Department of Defense for national security.
–defense.govWashington, D.C., United States
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Tecan

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Tecan

254 people are tracked at Tecan (84 in leadership, 6 in board & advisors, 164 in team); the tracked headcount is 3,590.

NameRoleGroup
Monica Manotas
CEOLeadership
Eric Thelen
Head Of Sales - Southeast USLeadership
Mukta Acharya
EVP & Head, Life Sciences BusinessLeadership
Jen Clancy
Vice President Marketing & Client ServicesLeadership
Jenny Zhao
Head Of Finance And Controlling ParamitLeadership
Reggie Stotts
Sales Director OEM Components AmericasLeadership
Barbara S.
Head Of Sales Support OEM BusinessLeadership
Marcel Rutishauser
Senior Director, R&d Project Management OfficeLeadership
Fulvio Valentino Garone
Global Head Quality Commercial OperationsLeadership
Lucile de Longeaux-Neubauer
Head Of Finance And Controlling Global Distributors And LSB Finance ProcessesLeadership
Martin Vorel
Head Of Legal & ComplianceLeadership
Nicole Suter
Executive Assistant To CFO And To Svp, Corp. Com & IR (85%)Leadership
Fabio Rimensberger
Director Product Mgmt. & Portfolio Strategy – Liha PlatformsLeadership
Isabell Liebe
Head Quality Europe & LabwerxLeadership
Sandro Hutter
Associate Director Product ManagementLeadership
Taunya Alexander
VP QARA ManagementLeadership
Drew Campbell
Director QARALeadership
Bogdan Gerya
VP Corporate DevelopmentLeadership
Erik Norström
EVP, Head of Corporate DevelopmentLeadership
Greg Thompson
Head Of Labwerx, USLeadership

234 more people are available in the full profile.

Premium access

Complete people profiles for Tecan

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Tecan

Tecan is a publicly listed company on the SIX with ticker symbol TECN in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date06 Jun 2003
  • Listed onSWX: TECN
  • Listed entityTecan Group AG
  • Exchange sectorHealth technology
  • ISINCH0012100191
  • Share price133.70 CHF (+1.44% on the day) · 2026-05-11
  • Market capitalisation1,690,451,407.00 CHF
  • Price to earnings26.6
  • EPS (diluted, trailing year)-8.74 CHF
  • Dividend yield2.28%
  • Volume (last session)8,476
  • Analyst consensusBuy

Financials of Tecan

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025882.5M CHF-110.7M CHF86.2M CHF
2024934.3M CHF67.7M CHF141.5M CHF
20231.07B CHF132.1M CHF201.7M CHF
20221.14B CHF121.1M CHF213.0M CHF
2021946.6M CHF121.7M CHF200.2M CHF
Premium access

Detailed financial statements for Tecan

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Tecan

Tecan has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include IBL International, NuGEN and Paramit.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of contract manufacturing services for medical devices and life science instruments
paramit.comMorgan Hill, United States1990Jun 2021$1B
Amplification products for genomic analysis are developed and supplied.
nugen.comSan Carlos, United States2000Aug 2018$54.5M
High-performance machines and equipment are designed and manufactured.
pulssar-technologies.comParis, France2005Apr 2017••••
-
spewarecorporation.com–0Aug 2016••••
Multi-tipped robotic liquid handling systems are developed for lab automation.
sias.bizHombrechtikon, Switzerland2000Oct 2015••••
Immunoassays and antibodies are supplied for diagnostic applications in labs.
ibl-international.comMannedorf, Switzerland1980Jul 2014$38.94M
Develops sample storage and processing systems
remp.comOberdiessbach, Switzerland1986Jun 2005$94.09M
Premium access

Complete acquisition details for Tecan

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Tecan

11 dated milestones of Tecan across 41 years, from founding to its latest funding, stage changes and deals.

  1. Founded Tecan is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires REMP.
  4. Acquisition Acquires IBL International.
  5. Funding First funding round.
  6. Acquisition Acquires Sias.
  7. Acquisition Acquires Spewarecorporation.
  8. Acquisition Acquires Pulssar Technologies.
  9. Acquisition Acquires NuGEN.
  10. Funding Latest funding round, Grant, of $32.9M.
  11. Acquisition Acquires Paramit.

Competitors of Tecan

Tecan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, Waters Corporation, Emerald Therapeutics, Andrew Alliance and Quartzy, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
opentrons.com2013Brooklyn, United States$240.56M177
Pipetting robots for laboratory automation are developed.
waters.com1958Milford, United States–9,341
Provider of laboratory management system for researchers and clinicians
emeraldcloudlab.com2010San Francisco, United States$39.5M77
Cloud-based remote lab automation software is offered for life sciences.
andrewalliance.com2011Vernier, Switzerland$14.03M5
Provider of automated liquid handling tools and software for scientific labs
quartzy.com2009Palo Alto, United States$33.87M97
Lab management platform for life sciences is offered by Quartzy.
labcyte.com2000Sunnyvale, United States$33.39M184
Acoustic liquid handling is developed for life science research.
creliohealth.com2013Pune, India$1.5M156
SaaS-based laboratory information system is provided for clinicians.
synthace.com2011London, United Kingdom$80.27M68
SaaS-based laboratory automation software is provided for researchers.
automata.tech2015London, United Kingdom$106.51M151
Lab automation robots are provided for life sciences applications.
Premium access

Detailed competitors of Tecan

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Tecan

The website of Tecan (tecan.com) receives about 86.6K visits a month.

  • Monthly visits
    86.6K

    ▲ 19.5% vs previous month

Similar websites

Websites whose visitors overlap most with Tecan. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
biotek.com
100%
––View details
hoeferinc.com
hoeferinc.com
95%
–#5,638,048–
percival-scientific.com
95%
3.5K#4,523,249View details
nuaire.com
95%
24.1K#1,251,691View details
moleculardevices.com
93%
131.7K#329,224View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Tecan

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Tecan

Premium access

Complete news archive for Tecan

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Tecan

10 companies that operate in the same segment as Tecan (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Tecan

Tecan was founded in 1980 and raised its 1st funding round 35 years after it was founded.

Tecan is headquartered in Mannedorf, Switzerland. It is registered at Mannedorf, Zurich, Switzerland.

Tecan has 3,590 employees.

Annual revenue of Tecan is $1.11B as on Dec 31, 2025.

Tecan was founded in 1980 and is headquartered in Mannedorf, Switzerland. Operations focus on the life sciences and diagnostics sectors, where automated laboratory instruments and solutions are developed and supplied. Key offerings include Fluent laboratory automation systems, liquid handling robotics, readers and washers, microarray scanners, software for workflow management, and immunoassay diagnostics with integrated automation. Global distribution supports research, clinical, and industrial applications in laboratory environments.

Tecan's top competitors include Opentrons, Waters Corporation and Andrew Alliance.

Yes, Tecan is publicly traded on SIX under the ticker symbol TECN.

Tecan has made 7 acquisitions, including IBL International, NuGEN, and Paramit.

Tecan has 3 investors. Key investors include HHS, European Union, and U.S. Department of Defense.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available